Meyka Pro banner
Cardinal Health, Inc.

Cardinal Health, Inc. Fundamental Analysis (NYSE: CAH)

CAH●NYSE
HealthcareMedical - Distribution
$272.81
$0.47(0.17%)
U.S. Market opens in 51h 34m

Cardinal Health, Inc. Fundamental Analysis (NYSE: CAH)

Cardinal Health, Inc. (NYSE: CAH) shows weak financial fundamentals with a PE ratio of 35.45, profit margin of 0.71%, and ROE of -62.56%. The company generates $256.8B in annual revenue with weak year-over-year growth of -1.87%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE-62.56%
Operating Margin1.05%
PEG Ratio2.14
Current Ratio0.88
We analyze CAH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 4.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
4.7/100

We analyze CAH's fundamental strength across five key dimensions:

Efficiency Score

Weak

CAH struggles to generate sufficient returns from assets.

ROA > 10%
3.05%

Valuation Score

Weak

CAH trades at a premium to fair value.

PE < 25
35.45
PEG Ratio < 2
2.14

Growth Score

Moderate

CAH shows steady but slowing expansion.

Revenue Growth > 5%
-1.87%
EPS Growth > 10%
86.21%

Financial Health Score

Moderate

CAH shows balanced financial health with some risks.

Debt/Equity < 1
-2.91
Current Ratio > 1
0.88

Profitability Score

Weak

CAH struggles to sustain strong margins.

ROE > 15%
-6256.02%
Net Margin ≥ 15%
0.71%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CAH Expensive or Cheap?

P/E Ratio

CAH trades at 35.45 times earnings. This suggests a premium valuation.

35.45

PEG Ratio

When adjusting for growth, CAH's PEG of 2.14 indicates potential overvaluation.

2.14

Price to Book

The market values Cardinal Health, Inc. at -21.07 times its book value. This may indicate undervaluation.

-21.07

EV/EBITDA

Enterprise value stands at 16.77 times EBITDA. This signals the market has high growth expectations.

16.77

How Well Does CAH Make Money?

Net Profit Margin

For every $100 in sales, Cardinal Health, Inc. keeps $0.71 as profit after all expenses.

0.71%

Operating Margin

Core operations generate 1.05 in profit for every $100 in revenue, before interest and taxes.

1.05%

ROE

Management delivers $-62.56 in profit for every $100 of shareholder equity.

-62.56%

ROA

Cardinal Health, Inc. generates $3.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.05%

Following the Money - Real Cash Generation

Operating Cash Flow

Cardinal Health, Inc. generates limited operating cash flow of $5.58B, signaling weaker underlying cash strength.

$5.58B

Free Cash Flow

Cardinal Health, Inc. generates weak or negative free cash flow of $4.88B, restricting financial flexibility.

$4.88B

FCF Per Share

Each share generates $21.13 in free cash annually.

$21.13

FCF Yield

CAH converts 7.74% of its market value into free cash.

7.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

35.45

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.14

vs 25 benchmark

P/B Ratio

Price to book value ratio

-21.07

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.25

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.91

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.88

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.63

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.20

vs 25 benchmark

How CAH Stacks Against Its Sector Peers

MetricCAH ValueSector AveragePerformance
P/E Ratio35.4530.24 Worse (Expensive)
ROE-62.56%540.00% Weak
Net Margin0.71%-2322.00% (disorted) Weak
Debt/Equity-2.910.08 Strong (Low Leverage)
Current Ratio0.885.59 Weak Liquidity
ROA3.05%-17516.00% (disorted) Weak

CAH outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cardinal Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

76.96%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

151.39%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

48.68%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ